These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28469335)

  • 21. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
    Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM
    Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteogenic tumors of bone].
    Jobke B; Werner M
    Radiologe; 2016 Jun; 56(6):489-506. PubMed ID: 27255551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periosteal osteosarcoma of the jaws: report of 2 cases.
    Piattelli A; Favia GF
    J Periodontol; 2000 Feb; 71(2):325-9. PubMed ID: 10711625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review.
    Jimmy R; Stern C; Lisy K; White S
    JBI Database System Rev Implement Rep; 2017 Aug; 15(8):2113-2152. PubMed ID: 28800058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteosarcoma: a review of current and future therapeutic approaches.
    Zhao X; Wu Q; Gong X; Liu J; Ma Y
    Biomed Eng Online; 2021 Mar; 20(1):24. PubMed ID: 33653371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteosarcoma subtypes: Magnetic resonance and quantitative diffusion weighted imaging criteria.
    Zeitoun R; Shokry AM; Ahmed Khaleel S; Mogahed SM
    J Egypt Natl Canc Inst; 2018 Mar; 30(1):39-44. PubMed ID: 29429892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteosarcoma (osteogenic sarcoma).
    Picci P
    Orphanet J Rare Dis; 2007 Jan; 2():6. PubMed ID: 17244349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of recurrence of musculoskeletal tumors with thallium-201 scintigraphy plus SPECT/CT in pediatric population].
    Medina-Ornelas SS; Vera-Hermosillo H; Delgado-Espín R; García-Pérez FO
    Bol Med Hosp Infant Mex; 2018; 75(1):31-40. PubMed ID: 29652875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low grade intramedullary osteosarcoma. Apropos of 8 cases].
    Katabi M; Anract P; Forest M; Tomeno B
    Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(3):208-15. PubMed ID: 9005458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
    Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
    Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models.
    Fleuren ED; Versleijen-Jonkers YM; Roeffen MH; Franssen GM; Flucke UE; Houghton PJ; Oyen WJ; Boerman OC; van der Graaf WT
    Int J Cancer; 2014 Dec; 135(12):2770-82. PubMed ID: 24771207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients.
    Sharp SE; Shulkin BL; Gelfand MJ; McCarville MB
    Pediatr Radiol; 2017 Dec; 47(13):1800-1808. PubMed ID: 28887617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiopharmaceuticals for Treatment of Osteosarcoma.
    Anderson PM
    Adv Exp Med Biol; 2020; 1257():45-53. PubMed ID: 32483729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Popliteal lymph nodes in patients with osteosarcoma: are they metastatic?
    Cleary MX; Fayad LM; Ahlawat S
    Skeletal Radiol; 2020 Nov; 49(11):1807-1817. PubMed ID: 32519180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives.
    Mercatelli D; Bortolotti M; Bazzocchi A; Bolognesi A; Polito L
    Biomedicines; 2018 Feb; 6(1):. PubMed ID: 29439419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.
    Kato S; Gasbarrini A; Ghermandi R; Gambarotti M; Bandiera S
    Eur Spine J; 2016 May; 25 Suppl 1():251-6. PubMed ID: 27052403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging characteristics of primary osteosarcoma: nonconventional subtypes.
    Yarmish G; Klein MJ; Landa J; Lefkowitz RA; Hwang S
    Radiographics; 2010 Oct; 30(6):1653-72. PubMed ID: 21071381
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.